Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A phase I-II dose ranging study of BMS-275183 (oral taxane) in combination with pemetrexed
(Alimta) in patients with recurrent Non-Small Cell Lung Cancer (NSCLC). The safety and
efficacy of this combination will be studied.